Q
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 55.5 KBQ Therapeutics, Inc.Feb 12, 6:02 PM ET·0001209191-16-098217
- 55.1 KBQ Therapeutics, Inc.Feb 12, 5:19 PM ET·0001209191-16-098169
- 4/A10.3 KBQ Therapeutics, Inc.Feb 12, 5:02 PM ET·0001209191-16-098143
- 8-K13.5 KBQ Therapeutics, Inc.Dec 17, 5:10 PM ET·0001193125-15-406382
- 35.5 KBQ Therapeutics, Inc.Nov 23, 5:14 PM ET·0001209191-15-081813
- 8-K50.2 KBQ Therapeutics, Inc.Nov 18, 9:04 PM ET·0001193125-15-381074
- 10-Q2.4 MBQ Therapeutics, Inc.Nov 13, 2:45 PM ET·0001193125-15-376922
- 8-K95.8 KBQ Therapeutics, Inc.Sep 14, 5:08 PM ET·0001193125-15-319570
- 410.2 KBQ Therapeutics, Inc.Sep 11, 3:20 PM ET·0001209191-15-070308
- 10-Q2.3 MBQ Therapeutics, Inc.Aug 14, 1:36 PM ET·0001193125-15-291454
Insiders
10- BORST STEVEN JOHNCFO & VP of Corp. Development
- EPPSTEIN DEBORAH ANNECEO & President, Director
- GOSWAMI JOYDEEPDirector
- GREBOW PETER EDirector
- Green David AChief Financial Officer
- HUTT PETER BARTONDirector
- Jorkasky DianeDirector
- PATEL DINESH CDirector
- Q Therapeutics, Inc.Chief Financial Officer
- Rao Mahendra S.Chief Strategy Officer
Tickers
No tickers on record
Addresses
business
615 ARAPEEN DRIVE SUITE 102
SALT LAKE CITY, UT, 84108
mailing
615 ARAPEEN DRIVE SUITE 102
SALT LAKE CITY, UT, 84108
Former Names
- Q Holdings, Inc.2012-12-18
- Grace 2, Inc.2011-12-02